Connor, Clark & Lunn Investment Management Ltd. A Tyr Pharma Inc Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $28.9 Billion
- Q3 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 20,994 shares of LIFE stock, worth $39,048. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,994Holding current value
$39,048% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LIFE
# of Institutions
133Shares Held
42.4MCall Options Held
4.77MPut Options Held
5.15M-
Federated Hermes, Inc. Pittsburgh, PA10.5MShares$19.6 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$10.5 Million0.0% of portfolio
-
Ubs Group Ag4.51MShares$8.38 Million0.0% of portfolio
-
State Street Corp Boston, MA4.2MShares$7.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.18MShares$4.05 Million0.0% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...